Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

24-hour Electro-cardiographic Monitoring in Hip Fracture Patients

October 6, 2022
admin
24-hour electrocardiographic monitoring is often requested in patients with a fractured neck of femur, with a limited evidence base to support its use in such patients.

Toujeo now available for UK adults with diabetes

October 6, 2022
admin
The new once-daily basal insulin Toujeo has become available for clinicians to prescribe in the UK, providing another option for adults with type 1 and type 2 diabetes mellitus to help manage their condition.

Clinicians warned to stub out smoking complacency

April 18, 2024
Dr Kiran Patel
Smoking is still a major challenge for clinicians, despite recent successes, argues Dr Kiran Patel, medical director of NHS England (West Midlands) and consultant cardiologist, Heart of England NHS Trust

Unpaid carers foot the bill of cancer care

October 6, 2022
admin
Unpaid carers to people with terminal cancer provide health and social care worth £219 million each year. This accounts for one third of the cost of end-of-life care for people with breast, lung, colorectal and prostate cancers, according to researchers at University College London (UCL). 

Disappointment for people with lupus as drug trial fails to meet target

October 6, 2022
admin
Two Phase 3 clinical trials for epratuzumab in Systemic Lupus Erythematosus (SLE) did not meet primary endpoint, pharmaceutical UCB has announced.

Spotlight: Ovarian cancer

April 18, 2024
Dr Sharon Tate
Understanding the symptoms and acting early can save hundreds of lives when it comes to treating ovarian cancer. Here, the author looks at the challenges and emphasises the need for swift and effective diagnosis

Managing female obesity

April 18, 2024
Dr Jane Wilcock
Obesity in women extends beyond CVD risks to contraception, conception, pregnancy, neonatal and cancer risks

New developments in childhood asthma treatment

April 18, 2024
Dr Jayesh Bhatt
Asthma is a clinical condition characterised by recurrent symptoms of wheeze, cough, chest tightness and breathlessness. It is common and an important cause of morbidity and mortality.

Path of least antimicrobial resistance

April 18, 2024
Dr Bianca Potterton
Antimicrobial resistance threatens the effective treatment of a wide range of infections, and GPs have a crucial role to play in the leading the fight back.

New melanoma drug approved by European Commission

October 6, 2022
admin
The European Commission has granted a marketing authorisation for pembrolizumab (Keytruda) as monotherapy for the treatment of advanced (unresectable or metastatic) melanoma in adults

Major study shows reduction in breast cancer deaths

October 6, 2022
admin
A class of hormonal drugs called aromatase inhibitors substantially reduce the risk of death in postmenopausal women with the most common type of breast cancer, a major study of more than 30,000 women shows.

The GP and bariatric surgery: Part 2

April 18, 2024
Bussa Rao Gopinath
Bariatric surgery is increasingly recognised as a viable approach to effective weight-loss management. In part two of a new series the authors discuss the different types of bariatric surgery.

Tailoring hypertension management in newly diagnosed patients

April 18, 2024
Dr John Cannon
Successfully managing hypertension can be tricky due to numerous variables and risk factors. Here, the author considers how treatment can be tailored for newly diagnosed patients

EMA revise class waiver list to stimulate development of medicines for children

October 6, 2022
admin
The European Medicines Agency's Paediatric Committee has revised the current list of class waivers for medicines that are not required to submit a paediatric investigation plan.

EMA gives positive opinion on first malaria vaccine

October 6, 2022
admin
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive scientific opinion for Mosquirix (Plasmodium falciparum and hepatitis B vaccine), for use outside the European Union (EU).

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy